Streetbeat News

Regulatory

PALI

Palisade Bio's stock is plummeting after the company announced that its Phase 2 PROFILE study of LB1148 for post-surgical abdominal adhesions did not achieve its primary endpoint. The trial was paused due to COVID-19 and restarted with an amended protocol in May 2022. The topline data showed that LB1148 did not reduce adhesions in treated patients compared to placebo-treated patients. The company does not believe the results support further development of LB1148 for a reduction in intra-abdominal adhesions. PALI shares are down 67.7%.

Portfolio Pulse from Vandana Singh

August 09, 2023 | 1:31 pm

ADBE

VGK

The European Union has extended the review of the Adobe/Figma deal by 10 working days, setting a new deadline of January 8, 2024. This follows the EU's decision to open an in-depth probe into the deal.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:27 pm

BLK

BTCUSD

Billionaire David Rubenstein, co-founder of The Carlyle Group, expressed his confidence in Bitcoin's endurance due to the global interest it attracts. He also pointed out that major financial firms like BlackRock and Fidelity are seeking approval to launch Bitcoin ETFs. Other companies such as Valkyrie, WisdomTree, VanEck, Ark Invest, and Invesco are also applying for a Bitcoin ETF.

Portfolio Pulse from Murtuza Merchant

August 09, 2023 | 1:24 pm

AMZN

Amazon has lost two key executives from its drone delivery unit, Prime Air, amid ongoing struggles with the service. The departures of Jim Mullin, Prime Air's chief pilot, and Robert Dreer, responsible for all of Prime Air's test operations, come as the service has struggled to expand beyond tests in two small U.S. markets. The drone unit has been hampered by regulatory restrictions, a string of crashes, and a failure to meet delivery targets. The departures could impact Amazon's ability to meet key regulatory requirements of the Federal Aviation Administration.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:23 pm

YELL

Yellow Corp has been notified by the Nasdaq Stock Market LLC that trading of its common stock will be suspended at the opening of business on August 16, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:22 pm

SBLK

Star Bulk Carriers' President, Hamish Norton, discussed the company's Q2 2023 financial results, business strategy, and outlook for the dry bulk market in a recent podcast. He highlighted fleet renewal, upgrades for fuel efficiency and emission compliance, carbon capture, and capital allocation. He also discussed the supply and demand side of the dry bulk outlook and shipowners investing in dry bulk shipping.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:20 pm

IPA

Immunoprecise Antibodies Ltd. (IPA) has responded to a Schedule 13D filing by investment manager Ingalls & Snyder, LLC, stating that it values input from shareholders and is committed to acting in the best interest of IPA. The company has begun interviewing potential candidates to refresh its board of directors. Additionally, IPA has adopted a majority voting policy, requiring any director who receives more 'withheld' votes than 'for' votes to tender their resignation.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:19 pm

LEXX

Lexaria Bioscience Corp has reported results from its 2023 human oral nicotine study NIC-H22-1. The study compared Lexaria's DehydraTECH-Nicotine tobacco-free pouch to ZYN.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:19 pm

GCI

GETY

Global news and publishing organizations have signed an open letter proposing principles for the regulated and responsible growth of generative AI models. The letter outlines regulatory and industry actions to protect the content powering AI applications and preserve public trust in media. Signatories include Agence France-Presse, European Pressphoto Agency, European Publishers' Council, Gannett | USA TODAY Network, Getty Images, National Press Photographers Association, National Writers Union, News Media Alliance, The Associated Press, and The Authors Guild.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:59 pm

AVNS

Trading of Avanos Medical shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:43 pm